Loading…
Design, Synthesis and Characterization of Cyclic NU172 Analogues: A Biophysical and Biological Insight
NU172-a 26-mer oligonucleotide able to bind exosite I of human thrombin and inhibit its activity-was the first aptamer to reach Phase II clinical studies as an anticoagulant in heart disease treatments. With the aim of favoring its functional duplex-quadruplex conformation and thus improving its enz...
Saved in:
Published in: | International journal of molecular sciences 2020-05, Vol.21 (11), p.3860 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c484t-ce4d0fde2a9e957a0c724890e6cb1a2ed67cf4b0323dc78e7b94d2ab561301223 |
---|---|
cites | cdi_FETCH-LOGICAL-c484t-ce4d0fde2a9e957a0c724890e6cb1a2ed67cf4b0323dc78e7b94d2ab561301223 |
container_end_page | |
container_issue | 11 |
container_start_page | 3860 |
container_title | International journal of molecular sciences |
container_volume | 21 |
creator | Riccardi, Claudia Meyer, Albert Vasseur, Jean-Jacques Cavasso, Domenico Russo Krauss, Irene Paduano, Luigi Morvan, François Montesarchio, Daniela |
description | NU172-a 26-mer oligonucleotide able to bind exosite I of human thrombin and inhibit its activity-was the first aptamer to reach Phase II clinical studies as an anticoagulant in heart disease treatments. With the aim of favoring its functional duplex-quadruplex conformation and thus improving its enzymatic stability, as well as its thrombin inhibitory activity, herein a focused set of cyclic NU172 analogues-obtained by connecting its 5'- and 3'-extremities with flexible linkers-was synthesized. Two different chemical approaches were exploited in the cyclization procedure, one based on the oxime ligation method and the other on Cu(I)-assisted azide-alkyne cycloaddition (CuAAC), affording NU172 analogues including circularizing linkers with different length and chemical nature. The resulting cyclic NU172 derivatives were characterized using several biophysical techniques (ultraviolet (UV) and circular dichroism (CD) spectroscopies, gel electrophoresis) and then investigated for their serum resistance and anticoagulant activity in vitro. All the cyclic NU172 analogues showed higher thermal stability and nuclease resistance compared to unmodified NU172. These favorable properties were, however, associated with reduced-even though still significant-anticoagulant activity, suggesting that the conformational constraints introduced upon cyclization were somehow detrimental for protein recognition. These results provide useful information for the design of improved analogues of NU172 and related duplex-quadruplex structures. |
doi_str_mv | 10.3390/ijms21113860 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_d93165f1d3ee4693a216d6bfff898992</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_d93165f1d3ee4693a216d6bfff898992</doaj_id><sourcerecordid>2409195148</sourcerecordid><originalsourceid>FETCH-LOGICAL-c484t-ce4d0fde2a9e957a0c724890e6cb1a2ed67cf4b0323dc78e7b94d2ab561301223</originalsourceid><addsrcrecordid>eNpdkktvEzEUhS0Eog_YsUazBKkB-9rjsVkghfBopAgW0LXl8SPjaDJO7Uml8OvrJKVKWfk-zv2ubR2E3hD8gVKJP4bVOgMhhAqOn6FzwgAmGPPm-Ul8hi5yXmEMFGr5Ep1RYKIWRJwj_9XlsByuqt-7YexKnCs92GrW6aTN6FL4q8cQhyr6arYzfTDVzxvSQDUddB-XW5c_VdPqS4ibbpeD0f1huuSleUjnQ8F34yv0wus-u9cP5yW6-f7tz-x6svj1Yz6bLiaGCTZOjGMWe-tASyfrRmPTlJtK7LhpiQZneWM8azEFak0jXNNKZkG3NScUEwB6ieZHro16pTYprHXaqaiDOhRiWiqdxmB6p6ykhNeeWOoc45JqINzy1nsvpJByz_p8ZG227dpZ44Yx6f4J9GlnCJ1axjvVUAIYcAG8PwK6_8aupwu1r2GQmDGo70jRvntYluJt-dZRrUM2ru_14OI2K2BYElkTJor06ig1KeacnH9kE6z2llCnlijyt6fPeBT_8wC9BxWPsXk</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2409195148</pqid></control><display><type>article</type><title>Design, Synthesis and Characterization of Cyclic NU172 Analogues: A Biophysical and Biological Insight</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>PubMed Central</source><creator>Riccardi, Claudia ; Meyer, Albert ; Vasseur, Jean-Jacques ; Cavasso, Domenico ; Russo Krauss, Irene ; Paduano, Luigi ; Morvan, François ; Montesarchio, Daniela</creator><creatorcontrib>Riccardi, Claudia ; Meyer, Albert ; Vasseur, Jean-Jacques ; Cavasso, Domenico ; Russo Krauss, Irene ; Paduano, Luigi ; Morvan, François ; Montesarchio, Daniela</creatorcontrib><description>NU172-a 26-mer oligonucleotide able to bind exosite I of human thrombin and inhibit its activity-was the first aptamer to reach Phase II clinical studies as an anticoagulant in heart disease treatments. With the aim of favoring its functional duplex-quadruplex conformation and thus improving its enzymatic stability, as well as its thrombin inhibitory activity, herein a focused set of cyclic NU172 analogues-obtained by connecting its 5'- and 3'-extremities with flexible linkers-was synthesized. Two different chemical approaches were exploited in the cyclization procedure, one based on the oxime ligation method and the other on Cu(I)-assisted azide-alkyne cycloaddition (CuAAC), affording NU172 analogues including circularizing linkers with different length and chemical nature. The resulting cyclic NU172 derivatives were characterized using several biophysical techniques (ultraviolet (UV) and circular dichroism (CD) spectroscopies, gel electrophoresis) and then investigated for their serum resistance and anticoagulant activity in vitro. All the cyclic NU172 analogues showed higher thermal stability and nuclease resistance compared to unmodified NU172. These favorable properties were, however, associated with reduced-even though still significant-anticoagulant activity, suggesting that the conformational constraints introduced upon cyclization were somehow detrimental for protein recognition. These results provide useful information for the design of improved analogues of NU172 and related duplex-quadruplex structures.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms21113860</identifier><identifier>PMID: 32485818</identifier><language>eng</language><publisher>Switzerland: MDPI</publisher><subject>Analytical chemistry ; Anticoagulants - chemical synthesis ; Aptamers, Nucleotide - chemical synthesis ; biophysical characterization ; Chemical Sciences ; Circular Dichroism ; cyclization ; Cycloaddition Reaction - methods ; DNA aptamers ; duplex/quadruplex ; Fibrinogen - chemistry ; G-quadruplex ; G-Quadruplexes ; Medicinal Chemistry ; NU172 ; Organic chemistry ; Oximes - chemistry ; Ultraviolet Rays</subject><ispartof>International journal of molecular sciences, 2020-05, Vol.21 (11), p.3860</ispartof><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c484t-ce4d0fde2a9e957a0c724890e6cb1a2ed67cf4b0323dc78e7b94d2ab561301223</citedby><cites>FETCH-LOGICAL-c484t-ce4d0fde2a9e957a0c724890e6cb1a2ed67cf4b0323dc78e7b94d2ab561301223</cites><orcidid>0000-0002-7182-0757 ; 0000-0001-6295-6911 ; 0000-0001-8124-6034 ; 0000-0002-1105-4237 ; 0000-0001-5077-0028 ; 0000-0002-4379-6139</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312020/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312020/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,37013,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32485818$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-02904425$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Riccardi, Claudia</creatorcontrib><creatorcontrib>Meyer, Albert</creatorcontrib><creatorcontrib>Vasseur, Jean-Jacques</creatorcontrib><creatorcontrib>Cavasso, Domenico</creatorcontrib><creatorcontrib>Russo Krauss, Irene</creatorcontrib><creatorcontrib>Paduano, Luigi</creatorcontrib><creatorcontrib>Morvan, François</creatorcontrib><creatorcontrib>Montesarchio, Daniela</creatorcontrib><title>Design, Synthesis and Characterization of Cyclic NU172 Analogues: A Biophysical and Biological Insight</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>NU172-a 26-mer oligonucleotide able to bind exosite I of human thrombin and inhibit its activity-was the first aptamer to reach Phase II clinical studies as an anticoagulant in heart disease treatments. With the aim of favoring its functional duplex-quadruplex conformation and thus improving its enzymatic stability, as well as its thrombin inhibitory activity, herein a focused set of cyclic NU172 analogues-obtained by connecting its 5'- and 3'-extremities with flexible linkers-was synthesized. Two different chemical approaches were exploited in the cyclization procedure, one based on the oxime ligation method and the other on Cu(I)-assisted azide-alkyne cycloaddition (CuAAC), affording NU172 analogues including circularizing linkers with different length and chemical nature. The resulting cyclic NU172 derivatives were characterized using several biophysical techniques (ultraviolet (UV) and circular dichroism (CD) spectroscopies, gel electrophoresis) and then investigated for their serum resistance and anticoagulant activity in vitro. All the cyclic NU172 analogues showed higher thermal stability and nuclease resistance compared to unmodified NU172. These favorable properties were, however, associated with reduced-even though still significant-anticoagulant activity, suggesting that the conformational constraints introduced upon cyclization were somehow detrimental for protein recognition. These results provide useful information for the design of improved analogues of NU172 and related duplex-quadruplex structures.</description><subject>Analytical chemistry</subject><subject>Anticoagulants - chemical synthesis</subject><subject>Aptamers, Nucleotide - chemical synthesis</subject><subject>biophysical characterization</subject><subject>Chemical Sciences</subject><subject>Circular Dichroism</subject><subject>cyclization</subject><subject>Cycloaddition Reaction - methods</subject><subject>DNA aptamers</subject><subject>duplex/quadruplex</subject><subject>Fibrinogen - chemistry</subject><subject>G-quadruplex</subject><subject>G-Quadruplexes</subject><subject>Medicinal Chemistry</subject><subject>NU172</subject><subject>Organic chemistry</subject><subject>Oximes - chemistry</subject><subject>Ultraviolet Rays</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpdkktvEzEUhS0Eog_YsUazBKkB-9rjsVkghfBopAgW0LXl8SPjaDJO7Uml8OvrJKVKWfk-zv2ubR2E3hD8gVKJP4bVOgMhhAqOn6FzwgAmGPPm-Ul8hi5yXmEMFGr5Ep1RYKIWRJwj_9XlsByuqt-7YexKnCs92GrW6aTN6FL4q8cQhyr6arYzfTDVzxvSQDUddB-XW5c_VdPqS4ibbpeD0f1huuSleUjnQ8F34yv0wus-u9cP5yW6-f7tz-x6svj1Yz6bLiaGCTZOjGMWe-tASyfrRmPTlJtK7LhpiQZneWM8azEFak0jXNNKZkG3NScUEwB6ieZHro16pTYprHXaqaiDOhRiWiqdxmB6p6ykhNeeWOoc45JqINzy1nsvpJByz_p8ZG227dpZ44Yx6f4J9GlnCJ1axjvVUAIYcAG8PwK6_8aupwu1r2GQmDGo70jRvntYluJt-dZRrUM2ru_14OI2K2BYElkTJor06ig1KeacnH9kE6z2llCnlijyt6fPeBT_8wC9BxWPsXk</recordid><startdate>20200529</startdate><enddate>20200529</enddate><creator>Riccardi, Claudia</creator><creator>Meyer, Albert</creator><creator>Vasseur, Jean-Jacques</creator><creator>Cavasso, Domenico</creator><creator>Russo Krauss, Irene</creator><creator>Paduano, Luigi</creator><creator>Morvan, François</creator><creator>Montesarchio, Daniela</creator><general>MDPI</general><general>MDPI AG</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-7182-0757</orcidid><orcidid>https://orcid.org/0000-0001-6295-6911</orcidid><orcidid>https://orcid.org/0000-0001-8124-6034</orcidid><orcidid>https://orcid.org/0000-0002-1105-4237</orcidid><orcidid>https://orcid.org/0000-0001-5077-0028</orcidid><orcidid>https://orcid.org/0000-0002-4379-6139</orcidid></search><sort><creationdate>20200529</creationdate><title>Design, Synthesis and Characterization of Cyclic NU172 Analogues: A Biophysical and Biological Insight</title><author>Riccardi, Claudia ; Meyer, Albert ; Vasseur, Jean-Jacques ; Cavasso, Domenico ; Russo Krauss, Irene ; Paduano, Luigi ; Morvan, François ; Montesarchio, Daniela</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c484t-ce4d0fde2a9e957a0c724890e6cb1a2ed67cf4b0323dc78e7b94d2ab561301223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Analytical chemistry</topic><topic>Anticoagulants - chemical synthesis</topic><topic>Aptamers, Nucleotide - chemical synthesis</topic><topic>biophysical characterization</topic><topic>Chemical Sciences</topic><topic>Circular Dichroism</topic><topic>cyclization</topic><topic>Cycloaddition Reaction - methods</topic><topic>DNA aptamers</topic><topic>duplex/quadruplex</topic><topic>Fibrinogen - chemistry</topic><topic>G-quadruplex</topic><topic>G-Quadruplexes</topic><topic>Medicinal Chemistry</topic><topic>NU172</topic><topic>Organic chemistry</topic><topic>Oximes - chemistry</topic><topic>Ultraviolet Rays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Riccardi, Claudia</creatorcontrib><creatorcontrib>Meyer, Albert</creatorcontrib><creatorcontrib>Vasseur, Jean-Jacques</creatorcontrib><creatorcontrib>Cavasso, Domenico</creatorcontrib><creatorcontrib>Russo Krauss, Irene</creatorcontrib><creatorcontrib>Paduano, Luigi</creatorcontrib><creatorcontrib>Morvan, François</creatorcontrib><creatorcontrib>Montesarchio, Daniela</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Riccardi, Claudia</au><au>Meyer, Albert</au><au>Vasseur, Jean-Jacques</au><au>Cavasso, Domenico</au><au>Russo Krauss, Irene</au><au>Paduano, Luigi</au><au>Morvan, François</au><au>Montesarchio, Daniela</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Design, Synthesis and Characterization of Cyclic NU172 Analogues: A Biophysical and Biological Insight</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2020-05-29</date><risdate>2020</risdate><volume>21</volume><issue>11</issue><spage>3860</spage><pages>3860-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>NU172-a 26-mer oligonucleotide able to bind exosite I of human thrombin and inhibit its activity-was the first aptamer to reach Phase II clinical studies as an anticoagulant in heart disease treatments. With the aim of favoring its functional duplex-quadruplex conformation and thus improving its enzymatic stability, as well as its thrombin inhibitory activity, herein a focused set of cyclic NU172 analogues-obtained by connecting its 5'- and 3'-extremities with flexible linkers-was synthesized. Two different chemical approaches were exploited in the cyclization procedure, one based on the oxime ligation method and the other on Cu(I)-assisted azide-alkyne cycloaddition (CuAAC), affording NU172 analogues including circularizing linkers with different length and chemical nature. The resulting cyclic NU172 derivatives were characterized using several biophysical techniques (ultraviolet (UV) and circular dichroism (CD) spectroscopies, gel electrophoresis) and then investigated for their serum resistance and anticoagulant activity in vitro. All the cyclic NU172 analogues showed higher thermal stability and nuclease resistance compared to unmodified NU172. These favorable properties were, however, associated with reduced-even though still significant-anticoagulant activity, suggesting that the conformational constraints introduced upon cyclization were somehow detrimental for protein recognition. These results provide useful information for the design of improved analogues of NU172 and related duplex-quadruplex structures.</abstract><cop>Switzerland</cop><pub>MDPI</pub><pmid>32485818</pmid><doi>10.3390/ijms21113860</doi><orcidid>https://orcid.org/0000-0002-7182-0757</orcidid><orcidid>https://orcid.org/0000-0001-6295-6911</orcidid><orcidid>https://orcid.org/0000-0001-8124-6034</orcidid><orcidid>https://orcid.org/0000-0002-1105-4237</orcidid><orcidid>https://orcid.org/0000-0001-5077-0028</orcidid><orcidid>https://orcid.org/0000-0002-4379-6139</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1422-0067 |
ispartof | International journal of molecular sciences, 2020-05, Vol.21 (11), p.3860 |
issn | 1422-0067 1661-6596 1422-0067 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_d93165f1d3ee4693a216d6bfff898992 |
source | Publicly Available Content Database (Proquest) (PQ_SDU_P3); PubMed Central |
subjects | Analytical chemistry Anticoagulants - chemical synthesis Aptamers, Nucleotide - chemical synthesis biophysical characterization Chemical Sciences Circular Dichroism cyclization Cycloaddition Reaction - methods DNA aptamers duplex/quadruplex Fibrinogen - chemistry G-quadruplex G-Quadruplexes Medicinal Chemistry NU172 Organic chemistry Oximes - chemistry Ultraviolet Rays |
title | Design, Synthesis and Characterization of Cyclic NU172 Analogues: A Biophysical and Biological Insight |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T08%3A35%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Design,%20Synthesis%20and%20Characterization%20of%20Cyclic%20NU172%20Analogues:%20A%20Biophysical%20and%20Biological%20Insight&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Riccardi,%20Claudia&rft.date=2020-05-29&rft.volume=21&rft.issue=11&rft.spage=3860&rft.pages=3860-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms21113860&rft_dat=%3Cproquest_doaj_%3E2409195148%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c484t-ce4d0fde2a9e957a0c724890e6cb1a2ed67cf4b0323dc78e7b94d2ab561301223%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2409195148&rft_id=info:pmid/32485818&rfr_iscdi=true |